This inventor holds 4 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: Novartis Ag, Yale University. Active years: 2019-2025.
Company Filing History:
Years Active: 2019-2025
Title: Innovations of Tejaskumar Pankajbhai Pathak
Introduction
Tejaskumar Pankajbhai Pathak is a notable inventor based in Boston, MA. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for various mental health disorders. With a total of four patents to his name, his work is recognized for its potential impact on treatment options.
Latest Patents
Among his latest patents are two innovative compounds: Methyl (R)-2-(fluoromethyl)-5-oxo-4-phenyl-4,5,6,7-tetrahydro-1H-cyclopenta[B]pyridine-3-carboxylate and methyl 2-(fluoromethyl)-5-oxo-4-phenyl-1,4,5,7-tetrahydrofuro[3,4-b]pyridine-3-carboxylate. These compounds are identified as CaV1.2 activators and are aimed at treating a range of conditions including schizophrenia, bipolar disorder, major depressive disorder, substance use disorder, ADHD, Phelan-McDermid Syndrome, autism spectrum disorder, multiple sclerosis, frontotemporal dementia, Alzheimer's disease, Brugada Syndrome, Short QT syndrome, and early repolarization syndrome.
Career Highlights
Tejaskumar has worked with prominent organizations such as Novartis AG and Yale University. His experience in these institutions has allowed him to collaborate with leading experts in the field, enhancing his research and development capabilities.
Collaborations
Some of his notable coworkers include James Neef and Amir Masoud Sadaghiani. Their collaborative efforts have contributed to the advancement of innovative solutions in the pharmaceutical industry.
Conclusion
Tejaskumar Pankajbhai Pathak's work exemplifies the spirit of innovation in the pharmaceutical sector. His contributions through patents and collaborations highlight the importance of research in developing effective treatments for complex health issues.